Pennant Reports 2020 Third Quarter Results

    NEXT STORY
    miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
    PREV STORY
    Adaptive Biotechnologies Announces Collaboration with GSK to Measure Minimal Residual Disease with clonoSEQ® Assay Across its Hematology and Oncology Portfolio
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Post-Hospital MRSA Infections Reduced By 30 Percent Through Use of Antiseptic Soap, Mouthwash, and Antibiotic Nasal Ointment

    Rockville, Md., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Methicillin-resistant Staphylococcus aureus (MRSA) infections and ...

    author_avatar
    NASDAQ Market News

    Novavax Announces Facility Expansion to Support Global Vaccine Development

    author_avatar
    NASDAQ Market News

    Junshi Biosciences and Lilly to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19

    author_avatar
    NASDAQ Market News